Filed: 8/14/2023ACC: 0001387131-23-009765
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 65 equity positions with a total reported market value of $286.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
65
Positions
$286.80M
Total AUM (reported)
47.85M
Total Shares
Allocation by class
COM$196.28M68.4%
SPONSORED ADS$28.91M10.1%
SHS$12.02M4.2%
NOTE 2.500% 3/1$9.45M3.3%
SPONSORED ADR$9.45M3.3%
COM NEW$8.98M3.1%
COMMON STOCK$7.15M2.5%
Portfolio Concentration
Top 3$65.64M22.9%
4–10$79.02M27.6%
11–25$87.09M30.4%
Rest$55.05M19.2%
Top 3 weight
22.9%
Top 10 weight
50.4%
Voting Authority Distribution
Total shares with voting rights: 47.85M
Sole
Full voting authority
47.85M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole65
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings65
Rows:
MADRIGAL PHARMACEUTICALS INC
SOLEShares145.60K
TypeSH
Market value$33.63M
11.73%
Sole
145.60K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares550K
TypeSH
Market value$17.48M
6.10%
Sole
550K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares211.61K
TypeSH
Market value$14.52M
5.06%
Sole
211.61K
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares321.02K
TypeSH
Market value$12.33M
4.30%
Sole
321.02K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.60M
TypeSH
Market value$12.05M
4.20%
Sole
1.60M
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares201.89K
TypeSH
Market value$11.57M
4.04%
Sole
201.89K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.05M
TypeSH
Market value$11.50M
4.01%
Sole
1.05M
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares40K
TypeSH
Market value$11.39M
3.97%
Sole
40K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares650K
TypeSH
Market value$10.54M
3.67%
Sole
650K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares910.32K
TypeSH
Market value$9.63M
3.36%
Sole
910.32K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares447.67K
TypeSH
Market value$9.46M
3.30%
Sole
447.67K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares12M
TypePRN
Market value$9.45M
3.30%
Sole
12M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares226.28K
TypeSH
Market value$7.15M
2.49%
Sole
226.28K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares411.13K
TypeSH
Market value$7.07M
2.47%
Sole
411.13K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares100K
TypeSH
Market value$6.83M
2.38%
Sole
100K
Shared
0.00
None
0.00
FIBROGEN INC
SOLEShares2.31M
TypeSH
Market value$6.23M
2.17%
Sole
2.31M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares900.72K
TypeSH
Market value$5.58M
1.94%
Sole
900.72K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares650.88K
TypeSH
Market value$5.42M
1.89%
Sole
650.88K
Shared
0.00
None
0.00
ASCENDIS PHARMA A S
SOLEShares57.76K
TypeSH
Market value$5.16M
1.80%
Sole
57.76K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares260K
TypeSH
Market value$4.93M
1.72%
Sole
260K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares60K
TypeSH
Market value$4.29M
1.50%
Sole
60K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares751.80K
TypeSH
Market value$4.19M
1.46%
Sole
751.80K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares125.15K
TypeSH
Market value$4.08M
1.42%
Sole
125.15K
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares1.59M
TypeSH
Market value$3.78M
1.32%
Sole
1.59M
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares300K
TypeSH
Market value$3.46M
1.21%
Sole
300K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 145.60K | SH | $33.63M 11.73% | 145.60K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 550K | SH | $17.48M 6.10% | 550K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 211.61K | SH | $14.52M 5.06% | 211.61K | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 321.02K | SH | $12.33M 4.30% | 321.02K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.60M | SH | $12.05M 4.20% | 1.60M | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 201.89K | SH | $11.57M 4.04% | 201.89K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.05M | SH | $11.50M 4.01% | 1.05M | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 40K | SH | $11.39M 3.97% | 40K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 650K | SH | $10.54M 3.67% | 650K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 910.32K | SH | $9.63M 3.36% | 910.32K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 447.67K | SH | $9.46M 3.30% | 447.67K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 12M | PRN | $9.45M 3.30% | 12M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 226.28K | SH | $7.15M 2.49% | 226.28K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 411.13K | SH | $7.07M 2.47% | 411.13K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 100K | SH | $6.83M 2.38% | 100K | 0.00 | 0.00 |
FIBROGEN INCSOLE | COM | 2.31M | SH | $6.23M 2.17% | 2.31M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 900.72K | SH | $5.58M 1.94% | 900.72K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 650.88K | SH | $5.42M 1.89% | 650.88K | 0.00 | 0.00 |
ASCENDIS PHARMA A SSOLE | SPONSORED ADR | 57.76K | SH | $5.16M 1.80% | 57.76K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 260K | SH | $4.93M 1.72% | 260K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 60K | SH | $4.29M 1.50% | 60K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 751.80K | SH | $4.19M 1.46% | 751.80K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 125.15K | SH | $4.08M 1.42% | 125.15K | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 1.59M | SH | $3.78M 1.32% | 1.59M | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 300K | SH | $3.46M 1.21% | 300K | 0.00 | 0.00 |
Page 1 of 3